Home ⟩ Insights

Insights

eurozone

6 min read • June 19, 2025

‘Hold The Line Or Pivot Hard’: Cannabis Industry Veterans Sound Off On Surviving 2025

4 min read • June 18, 2025

EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story

3 min read • April 1, 2025

Europe’s Top Cannabis B2B Event, ICBC, Returns To Berlin In April 2025

7 min read • March 22, 2025

This Week In Cannabis: The CDC’s Federal Weed Strategy, Edible Arrangements’ New Biz, Global News, Earnings, Musk And More

3 min read • February 21, 2025

Germany’s 2025 Election Could Make Or Break Cannabis Legalization: Here’s Where Key Parties Stand

16 min read • February 21, 2025

This Week In Cannabis: The MedMen Saga, Multi-Million-Dollar Financings, Controversies In LatAm And More

3 min read • February 17, 2025

Spain’s Largest Cannabis B2B Event, ICBC, Returns To Barcelona: Info, Discounts and More

3 min read • December 5, 2024

UK Set To Approve First Three CBD Products In 2025 After Public Consultation

2 min read • December 2, 2024

NASDAQ-Listed Weed Stock, High Tides Surges Over 21% In Last Two Sessions

3 min read • December 2, 2024

Conference Of Justice Ministers Approves Proposal To Revise German Cannabis Law

3 min read • November 28, 2024

Europe’s Top Cannabis Consumer Still Criminalizes Use, Forfeits Economic Gains

3 min read • November 25, 2024

Czech Government Approves Draft Law That Would Legalize Cultivation Of 3 Cannabis Plants, Possession Of 50 Grams (UPDATED)

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)